Solutions for companion animals
(and their people)
Piedmont knows how to bring successful animal health pharmaceutical products to market. Like bloodhounds on the scent, our team of experts excels at identifying needs in the marketplace and pursuing formulations that offer superior ease of use for pet owners.
- Based on independent market research, sales of Piedmont’s portfolio products are projected to reach $175 million annually by the end of 2020.
- We hold 44 patents, with 67 more (and counting) pending worldwide.
Innovation in action:
Our innovative chewable drug delivery platform for dogs and cats can deliver virtually any medication without a wrestling match. The soft, tasty, meat-free treat is made without water and without extrusion methods to protect the integrity and potency of active ingredients.
SOLITUDE™ IGR (cyromazine) is our patented, feed-through fly control compound for horses. Administered in alfalfa-based pellets, it reduces stable fly and house fly populations in barns by 95 to 100 percent. We launched Solitude in 2004 and in 2005 licensed the product to Pfizer Animal Health (which later became Zoetis).
We’ve developed and licensed truly remarkable animal health products and have more than 20 individual FDA-pharmaceuticals in our pipeline.